Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab and Chemotherapy in Operable Thoracic ESCC
NCT05199649Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2021
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial of sintilimab in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Species and abundance of gut microbiota at 2 years. Status: unknown.
02
Drugs
sintilimab
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT05199649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199649.